Anhui Fengyuan Pharmaceutical Co., Ltd. is principally engaged in the research, development, manufacture and distribution of biological medicines, Chinese medicines, as well as chemical synthetic medicines and preparations. The Company offers ibutilide fumarate injections for the treatment of cardiovascular diseases, cilnidipine tablets for the treatment of hypertension, aspirin-DL-lysine for injection reducing fever, Ruzengning Jiaonang for the treatment of hyperplasia of mammary glands, paracetanmol pseudophedrine sulfate and clemastine fumarate tablets for the treatment of influenza, diclofenac sodium patches for relieving pains, naftopidil tablets for the treatment of urinary obstruction and zalepion tablets for the treatment of insomnia. The Company operates its businesses mainly in the domestic market.